domingo, 26 de abril de 2026

The 340B Drug Pricing Program Is A Hidden Tax Expenditure Ike BrannonandAnthony T. Lo Sasso April 24, 2026

https://www.healthaffairs.org/content/forefront/340b-drug-pricing-program-hidden-tax-expenditure?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_J3hiiHPD9kz5rNBbMJoR-NntNxUMlR9Op0tuUKO9Wcyr5CWazGQ975omnzaLHgfvcMJnOTcpx1tbvK03H4K4Tby8JaA&_hsmi=415566602&utm_source=hasu Although 340B does not operate through the tax code, its economic effects mirror those of a tax expenditure. Recognizing it as such would not prejudge the program’s merits but would force a long-overdue accounting of its costs and encourage a more rational discussion of reform.

No hay comentarios: